ViewRay, Inc., a company that designs, manufactures, and markets the MRIdian MRI-Guided Radiation Therapy System, announced that it has reached an agreement with Hudson Executive Capital LP (HEC) to appoint Sai Nanduri, Senior Investment Analyst and representative of HEC, as an observer of the ViewRay Board of Directors (the “Board”), effective as of January 20, 2023.
The Company has also agreed that the Board will appoint Mr. Nanduri to fill any vacancy on the Board arising during the term of the agreement.
In connection with this announcement, ViewRay has also entered into a cooperation agreement with HEC, which currently owns approximately 8.7% of the Company’s outstanding common stock. Pursuant to its agreement with ViewRay, HEC has agreed to customary standstill and voting commitments, among other provisions.
The full agreement will be filed with the U.S. Securities and Exchange Commission on a Current Report on Form 8-K.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.